HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Davide Sala Selected Research

Tay-Sachs Disease

6/2022Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Davide Sala Research Topics

Disease

2Sandhoff Disease (Sandhoff's Disease)
06/2022 - 01/2020
2GM2 Gangliosidoses (GM2 Gangliosidosis)
06/2022 - 01/2020
1Tay-Sachs Disease
06/2022
1Insulin Resistance
01/2021
1ST Elevation Myocardial Infarction
01/2020
1Cystic Fibrosis (Mucoviscidosis)
01/2018
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Metachromatic Leukodystrophy (Sulfatide Lipidosis)
01/2017

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
01/2020 - 01/2017
1G(M2) Ganglioside (Ganglioside GM2)IBA
06/2022
1ZincIBA
01/2021
1Hexosaminidases (Hexosaminidase)IBA
01/2020
1UbiquitinIBA
01/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2018
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2018
1Cerebroside-Sulfatase (Arylsulfatase A)IBA
01/2017

Therapy/Procedure

2Therapeutics
06/2022 - 01/2020
1Investigational Therapies (Experimental Therapy)
06/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2022
1Extracorporeal Membrane Oxygenation
01/2020
1Transplantation
01/2017